EMA Data-Sharing Plan Seeks To Speed Up Relative Effectiveness Assessments
This article was originally published in The Pink Sheet Daily
Executive Summary
The European Medicines Agency wants to start sharing its regulatory assessment reports for drugs directly with individual health technology assessment bodies in the European Union to support rapid relative effectiveness assessments of drugs